Lagana A, Scalzulli E, Carmosino I, Bisegna ML, et al. Early predictive factors of molecular relapse in chronic phase-chronic myeloid leukemia (CP-CML) patients after tyrosine kinase inhibitor (TKI) discontinuation. Leuk Lymphoma 2025 Nov 20:1-5. doi: 10.1080/10428194.2025.2591778.
PMID: 41263141